This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Omuro Y, Matsumoto G, Sasaki T et al. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant 2003; 31: 943–945.
Goggins M, Offerhaus GJ, Hilgers W et al. Pancreatic adenocarcinomas with DNA replication errors are associated with wild-type K-ras and characteristic histopathology. Am J Pathol 1998; 152: 1501–1507.
Shono Y, Tanimura H, Iwahashi M et al. Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers. Br J Cancer 2003; 88: 530–536.
Gjertsen MK, Saeterdal I, Saeboe-Larssen S, Gaudernack G . HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes. J Mol Med 2003; 81: 43–50.
Yamamoto H, Itoh F, Nakamura H et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001; 61: 3139–3144.
Saeterdal I, Gjertsen MK, Straten P et al. A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells. Cancer Immunol Immunother 2001; 50: 469–476.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laghi, L., Castagna, L. & Malesci, A. Nonmyeloablative allogenic peripheral-blood stem-cell transplantation in pancreatic adenocarcinoma: one case, high expectations. Bone Marrow Transplant 33, 251 (2004). https://doi.org/10.1038/sj.bmt.1704331
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704331